PRKAA2 and neoplasm: Significantly, AMP-depleted tumour-derived cells obtained after BT-474 injection into mice showed a reduction in NANOG, OCT4 and BMI1 gene expression, providing evidence that AMPK can also drive transcriptional upregulation and maintenance of stemness markers in the in vivo tumour microenvironment (Fig. S2G).